BRAF and melanoma: We demonstrated that ACA-28 has a unique property to induce ERK-dependent apoptosis in melanoma cell lines (with either BRAF or NRAS mutation) as well as NIH/3T3 cells harboring mutationally active HER2/ErbB2 [16].